Literature DB >> 31392054

Upper gastrointestinal neoplasia in familial adenomatous polyposis: prevalence, endoscopic features and management.

Fábio Guilherme Campos1, Carlos Augusto Real Martinez1, Marianny Sulbaran1, Leonardo Alfonso Bustamante-Lopez1, Adriana Vaz Safatle-Ribeiro1.   

Abstract

BACKGROUND: To evaluate the prevalence of upper gastrointestinal (GI) polyps in familial adenomatous polyposis (FAP), and to discuss current therapeutic recommendations.
METHODS: Clinical, endoscopic, histological and treatment data were retrieved from charts of 102 patients [1958-2016]. Duodenal adenomatosis was classified according to Spigelman stages.
RESULTS: this series comprised 59 women (57.8%) and 43 men (42.1%) with a median age of 32.3 years. Patients underwent 184 endoscopic procedures, the first at a median age of 35.9 years (range, 13-75 years). Fundic gastric polyps (n=31; 30.4%) prevailed in the stomach. While only 5 adenomas were found in the stomach, 33 patients (32.4%) presented duodenal ones. Advanced lesions (n=13; 12.7%) were detected in the stomach (n=2) and duodenum (n=11). During follow-up, Spigelman stages improved in 6 (12.2%) patients, remained unchanged in 25 (51.0%) and worsened in 18 (36.7%). Carcinomas were diagnosed in the stomach and duodenum (4 lesions each, 3.9%), at median ages of 50.2 and 55.0 years, respectively. Advanced lesions and carcinomas were managed through local or surgical resections. Severe complications occurred in only 2 patients (one death). Enteroscopy in 21 patients revealed jejunal adenomas in 12, 11 of whom also presented duodenal adenomas.
CONCLUSIONS: There is a high prevalence of upper GI adenomas and cancer in FAP. There were diagnosed fundic gastric polyps (30.4%), duodenal (32.4%) and jejunal adenomas (11.8%), respectively. One third of duodenal polyps progressed slowly throughout the study. The rates of advanced gastroduodenal lesions (12.7%) and cancer (7.8%) raise the need for continuous surveillance during follow-up.

Entities:  

Keywords:  Familial adenomatous polyposis (FAP); adenomas; duodenum; small bowel; surveillance

Year:  2019        PMID: 31392054      PMCID: PMC6657332          DOI: 10.21037/jgo.2019.03.06

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  67 in total

1.  Natural history of ampullary adenoma in familial adenomatous polyposis: reconfirmation of benign nature during extended surveillance.

Authors:  T Matsumoto; M Iida; S Nakamura; K Hizawa; T Yao; M Tsuneyoshi; M Fujishima
Journal:  Am J Gastroenterol       Date:  2000-06       Impact factor: 10.864

Review 2.  Care of patients and their families with familial adenomatous polyposis.

Authors:  J E King; R R Dozois; N M Lindor; D A Ahlquist
Journal:  Mayo Clin Proc       Date:  2000-01       Impact factor: 7.616

3.  Management of duodenal adenomas in 98 patients with familial adenomatous polyposis.

Authors:  I Heiskanen; I Kellokumpu; H Järvinen
Journal:  Endoscopy       Date:  1999-08       Impact factor: 10.093

Review 4.  Gastroduodenal lesions in familial adenomatous polyposis.

Authors:  H Kashiwagi; A D Spigelman
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

5.  Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study.

Authors:  C J Groves; B P Saunders; A D Spigelman; R K S Phillips
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

6.  Periampullary adenomas and adenocarcinomas in familial adenomatous polyposis: cumulative risks and APC gene mutations.

Authors:  J Björk; H Akerbrant; L Iselius; A Bergman; Y Engwall; J Wahlström; T Martinsson; M Nordling; R Hultcrantz
Journal:  Gastroenterology       Date:  2001-11       Impact factor: 22.682

7.  The natural history of untreated duodenal and ampullary adenomas in patients with familial adenomatous polyposis followed in an endoscopic surveillance program.

Authors:  C A Burke; G J Beck; J M Church; R U van Stolk
Journal:  Gastrointest Endosc       Date:  1999-03       Impact factor: 9.427

8.  Histologic follow-up of ampullary adenomas in patients with familial adenomatosis coli.

Authors:  Y Noda; H Watanabe; M Iida; R Narisawa; I Kurosaki; M Iwafuchi; M Satoh; Y Ajioka
Journal:  Cancer       Date:  1992-10-01       Impact factor: 6.860

9.  The risk of upper gastrointestinal cancer in familial adenomatous polyposis.

Authors:  G J Offerhaus; F M Giardiello; A J Krush; S V Booker; A C Tersmette; N C Kelley; S R Hamilton
Journal:  Gastroenterology       Date:  1992-06       Impact factor: 22.682

10.  Worldwide survey among polyposis registries of surgical management of severe duodenal adenomatosis in familial adenomatous polyposis.

Authors:  W H de Vos tot Nederveen Cappel; H J Järvinen; J Björk; T Berk; G Griffioen; H F A Vasen
Journal:  Br J Surg       Date:  2003-06       Impact factor: 6.939

View more
  2 in total

1.  Prevalence of Gastroduodenal Polyps in Children With Familial Adenomatous Polyposis.

Authors:  James K Stone; Charles N Bernstein; Harminder Singh; Wael El-Matary
Journal:  J Can Assoc Gastroenterol       Date:  2020-12-24

2.  Genetic alteration of colorectal adenoma-carcinoma sequence among gastric adenocarcinoma and dysplastic lesions in a patient with attenuated familial adenomatous polyposis.

Authors:  Hiroki Tanabe; Kentaro Moriichi; Keitaro Takahashi; Yusuke Ono; Yu Kobayashi; Yuki Murakami; Takuya Iwama; Takehito Kunogi; Takahiro Sasaki; Katsuyoshi Ando; Nobuhiro Ueno; Shin Kashima; Hidehiro Takei; Yusuke Mizukami; Mikihiro Fujiya; Toshikatsu Okumura
Journal:  Mol Genet Genomic Med       Date:  2020-06-16       Impact factor: 2.183

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.